The issue of recreational use of sildenafil
DOI:
https://doi.org/10.12775/JEHS.2024.66.55563Keywords
sildenafil, viagra, recreationalAbstract
Introduction and purpose
Erectile dysfunction (ED) is defined as the inability to achieve and maintain an erection sufficient for satisfactory sexual intercourse. Sildenafil is one of the most popular medications used to treat ED, but in recent years, there has been a growing trend of recreational use of this drug, particularly among younger individuals, which can lead to numerous negative health consequences. The aim of this article is to provide an overview of the recreational use of sildenafil, especially among younger individuals.
State of knowledge
Sildenafil primarily affects the smooth muscle of the blood vessels in the corpora cavernosa, facilitating the achievement and maintenance of an erection. The most common side effects of sildenafil include headaches, dizziness, facial flushing, nausea, muscle pain, and nasal congestion. A relatively rare but potentially severe side effect of sildenafil is priapism. It is noted that those using sildenafil recreationally often have multiple sexual partners, as the drug helps them prolong sexual encounters. Studies show that sildenafil is used by groups that should have no problem achieving sexual satisfaction. The use of the drug in combination with alcohol and other substances is noticeable.
Conclusions
Recreational use of sildenafil appears to be an increasingly common behavior among young men who do not have difficulties achieving or maintaining an erection. There are no studies yet that specifically examine the recreational use of sildenafil among women. It is necessary to conduct further research to better understand the prevalence of this phenomenon and to identify the factors that predispose individuals to engage in recreational use of sildenafil.
References
Leslie SW, Sooriyamoorthy T. Erectile Dysfunction. In: StatPearls. Treasure Island (FL): StatPearls Publishing;
https://www.ncbi.nlm.nih.gov/books/NBK562253/ (access 2024.10.03)
Wang CM, Wu BR, Xiang P, Xiao J, Hu XC. Management of male erectile dysfunction: From the past to the future. Front Endocrinol (Lausanne). 2023; 27;14:1148834. https://doi.org/10.3389/fendo.2023.1148834
Yafi FA, Jenkins L, Albersen M, Corona G, et al. Erectile dysfunction. Nat Rev Dis Primers. 2016; 4;2:16003. https://doi.org/10.1038/nrdp.2016.3
McMahon CG. Current diagnosis and management of erectile dysfunction. Med J Aust. 2019; 210(10):469-476. doi: 10.5694/mja2.50167.
Salonia A, Bettocchi C, Boeri L, et al. EAU Working Group on Male Sexual and Reproductive Health. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction. Eur Urol. 2021; 80(3):333-357. https://doi.org/10.1016/j.eururo.2021.06.007
Smith BP, Babos M. Sildenafil In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
https://www.ncbi.nlm.nih.gov/books/NBK558978/ (access 03.10.2024)
Atsbeha BW, Kebede BT, Birhanu BS, et al. The Weekend Drug; Recreational Use of Sildenafil Citrate and Concomitant Factors: A Cross-Sectional Study. Front Med (Lausanne). 2021; 20;8:665247. https://doi.org/10.3389/fmed.2021.665247
Al Ibrahim AH, Ghallab KQ, Alhumaid FI, et al. A Systematic Review of Sildenafil Mortality Through the Years. Cureus. 2022; 4;14(12):e32179. doi: 10.7759/cureus.32179
Bhogal S, Khraisha O, Al Madani M, et al. Sildenafil for Pulmonary Arterial Hypertension. Am J Ther. 2019; 26(4):e520-e526. doi: 10.1097/MJT.0000000000000766.
Goldstein I, Burnett AL, Rosen RC, et al. The Serendipitous Story of Sildenafil: An Unexpected Oral Therapy for Erectile Dysfunction. Sex Med Rev. 2019; 7(1):115-128. https://doi.org/10.1016/j.sxmr.2018.06.005
Mitidieri E, Cirino G, d'Emmanuele di Villa Bianca R, Sorrentino R. Pharmacology and perspectives in erectile dysfunction in man. Pharmacol Ther. 2020; 208:107493. https://doi.org/10.1016/j.pharmthera.2020.107493
Roustit M, Giai J, Gaget O, et al. On-Demand Sildenafil as a Treatment for Raynaud Phenomenon: A Series of n-of-1 Trials. Ann Intern Med. 2018; 20;169(10):694-703. https://doi.org/10.7326/M18-0517
Tuiten A, van Rooij K, Bloemers J, et al. Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials. J Sex Med. 2018; 15(2):201-216. https://doi.org/10.1016/j.jsxm.2017.11.226
Dang ZC, Yang Z, Liu S, et al. Efficacy of Sildenafil on healthy humans in high‑altitude hypoxia at rest and during exercise: A meta‑analysis. Exp Ther Med. 2024 8;27(2):88. doi: 10.3892/etm.2024.12376
Gebreyohannes EA, Bhagavathula AS, Gebresillassie BM, et al. Recreational Use of Phosphodiesterase 5 Inhibitors and Its Associated Factors among Undergraduate Male Students in an Ethiopian University: A Cross-Sectional Study. World J Mens Health. 2016; 34(3):186-193. https://doi.org/10.5534/wjmh.2016.34.3.186
Cohen JL, Nees SN, Valencia GA, Rosenzweig EB, Krishnan US. Sildenafil Use in Children with Pulmonary Hypertension. J Pediatr. 2019; 205:29-34.e1. doi: 10.1016/j.jpeds.2018.09.067.
Coons JC, Pogue K, Kolodziej AR, Hirsch GA, George MP. Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update. Curr Cardiol Rep. 2019; 22;21(11):141. https://doi.org/10.1007/s11886-019-1235-4
Cook AM, Patuzzi RB. One mechanism of sudden sensorineural hearing loss after sildenafil and sexual activity. Int J Audiol. 2024; 1:1-4. doi: 10.1080/14992027.2024.2368577.
Rashid J, Patel B, Nozik-Grayck E, et al. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH). J Control Release. 2017; 28;250:96-106. doi: 10.1016/j.jconrel.2017.02.003
Delate T, Simmons VA, Motheral BR. Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002. Int J Impot Res. 2004;16(4):313-8. https://doi.org/10.1038/sj.ijir.3901191
Murtadha M, Raslan MA, Fahmy SF, et al. Changes in the Pharmacokinetics and Pharmacodynamics of Sildenafil in Cigarette and Cannabis Smokers. Pharmaceutics. 2021 13;13(6):876. doi: 10.3390/pharmaceutics13060876
Ouranidis A, Tsiaxerli A, Vardaka E, et al. Sildenafil 4.0-Integrated Synthetic Chemistry, Formulation and Analytical Strategies Effecting Immense Therapeutic and Societal Impact in the Fourth Industrial Era. Pharmaceuticals (Basel). 2021; 15;14(4):365. doi: 10.3390/ph14040365.
Rezaee ME, Gross MS. Are We Overstating the Risk of Priapism With Oral Phosphodiesterase Type 5 Inhibitors? J Sex Med. 2020; 17(8):1579-1582. https://doi.org/10.1016/j.jsxm.2020.05.019
Wanjari M, Late S. Use of Sildenafil in young adults: a growing health problem. Pan Afr Med J. 2023; 1;44:113. https://doi.org/10.11604/pamj.2023.44.113.39168
Mostafa T, Alghobary MF. Recreational Use of Oral PDE5 Inhibitors: The Other Side of Midnight. Sex Med Rev. 2022 Jul;10(3):392-402. https://doi.org/10.1016/j.sxmr.2021.10.004
Schreck B, Istvan M, Guerlais M, et al. New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session. Curr Drug Metab. 2023; 24(2):80-91. doi: 10.2174/1389200224666230228103922.
Almannie R, Alzahrani MA, Almuhaideb M, et al. Recreational use of oral erectile dysfunction medications among male physicians - A cross-sectional study. Urol Ann. 2023; 15(2):148-157. doi: 10.4103/ua.ua_33_22.
Johnson I, Thurman AR, Cornell KA, et al. Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial. Obstet Gynecol. 2024; 1;144(2):144-152.
doi: 10.1097/AOG.0000000000005648.
Lo Monte G, Graziano A, Piva I, et al. Women taking the "blue pill" (sildenafil citrate): such a big deal? Drug Des Devel Ther. 2014; 7;8:2251-4. https://doi.org/10.2147/DDDT.S71227
Gragasin FS, Michelakis ED, Hogan A, Moudgil R, Hashimoto K, Wu X, Bonnet S, Haromy A, Archer SL. The neurovascular mechanism of clitoral erection: nitric oxide and cGMP-stimulated activation of BKCa channels. FASEB J. 2004;18(12):1382-91. https://doi.org/10.1096/fj.04-1978com
Berman JR, Berman LA, Toler SM, et al. Sildenafil Study Group. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. J Urol. 2003; 170(6 Pt 1):2333-8.
Caruso S, Rugolo S, Agnello C, et al. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study. Fertil Steril. 2006; 85(5):1496-501. https://doi.org/10.1016/j.fertnstert.2005.10.043
Nurnberg HG, Hensley PL, Heiman JR, et al. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial. JAMA. 2008; 23;300(4):395-404. https://doi.org/10.1001/jama.300.4.395
Nazir MH, Ahmad M, Azeem S. Is recreational use of sildenafil a new trend? Ann Med Surg (Lond). 2022; 16;82:104659. doi: 10.1016/j.amsu.2022.104659.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Krystian Wdowiak, Agnieszka Maciocha, Julia Wąż, Aleksandra Witas, Justyna Drogoń, Weronika Chachaj, Paulina Słomka, Edyta Gwóźdź, Dawid Konieczko, Ewa Gardocka

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 114
Number of citations: 0